SCHEMBL4920225

SCHEMBL4920225

O=C(NO)c1ccc(CNCc2c(O)ccc3ccccc23)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 12/20 0.61
▸ HDAC8 Q9BY41 9/20 0.61
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ HDAC1 Q13547 8/20 0.57
▸ HDAC2 Q92769 5/20 0.57
▸ HDAC3 O15379 4/20 0.57
▸ HDAC4 P56524 4/20 0.57
▸ HDAC7 Q8WUI4 4/20 0.57
▸ HDAC10 Q969S8 4/20 0.57
▸ HDAC11 Q96DB2 4/20 0.57
▸ HDAC9 Q9UKV0 4/20 0.57
▸ HDAC5 Q9UQL6 4/20 0.57
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12531030 0.80 HSD17B10 (0.68) MEN1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL4920290 0.78 HDAC1 (0.72) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL5430042 0.75 KMT2A (1.00) HDAC6MEN1KMT2AHDAC1CYP1A2
SCHEMBL4925838 0.73 HDAC1 (0.60) HDAC6HDAC8KMT2AHDAC1HDAC2
SCHEMBL26086339 0.73 KCNT1 (0.51) MEN1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL10207296 0.71 HDAC6 (1.00) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL21163949 0.71 HSD17B10 (0.59) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL11593078 0.70 KCNT1 (0.60) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL2829167 0.70 HDAC6 (1.00) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL21369315 0.69 HDAC6 (0.72) HDAC6HDAC8HDAC1HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 — — US disclosed
CN-101087601-A Compounds for inhibiting copper-containing amine oxidases and uses thereof GENMEDICA THERAPEUTICS SL (ES) 2007-12-12 — — CN disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC6 2092/4885HDAC8 3399/4885MEN1 1562/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC6 2060/4885HDAC8 3570/4885MEN1 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback